NCT01465373View on ClinicalTrials.gov

Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs

PHASE4CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Infertility

Interventions

DRUG

Endometrin

100 mg per vagina TID

DRUG

Progesterone in Oil

50 mg IM injection daily

Trial Locations (1)

60610

Fertility Centers of Illinois, Chicago

Sponsors

Collaborators (1)

Ferring Pharmaceuticals

All Listed Sponsors

collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Fertility Centers of Illinois

OTHER

NCT01465373 - Vaginal Progesterone Versus Progesterone in Oil in Donor Egg Recipient In Vitro Fertilization Cycles Utilizing Vitrified Donor Eggs | Biotech Hunter | Biotech Hunter